Entity
  • Ochre Bio

    Created in 2019
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups
  • Social networks

    667 9,234
  • Activities

  • Entity types

  • Location

    Oxford, UK

    Oxford

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 61

  • Engaged corporates

    16
    3 15
  • Added in Motherbase

    3 years, 1 month ago
Description
  • Value proposition




    Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.

Corporate interactions BETA
Corporate TypeTweets Articles
Boston Consulting Group (BCG)
Boston Consulting Group (BCG)
Consulting, Business Consulting and Services
Boston Consulting Group (BCG)
Consulting, Business Consulting and Services
Other

22 Jul 2022


Entrepreneur First
Entrepreneur First
Startup accelerator & VC, Venture Capital and Private Equity Principals
Entrepreneur First
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

17 Jun 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

23 Sep 2023


Hello Tomorrow
Hello Tomorrow
Trade show, Business Consulting and Services
Hello Tomorrow
Trade show, Business Consulting and Services
Other

22 Jul 2022


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities
Other

13 Nov 2022


EU-Startups
EU-Startups
Media, Software Development
EU-Startups
Media, Software Development
Other

26 Jul 2024


Similar entities
Loading...
Loading...
Social network dynamics